Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA).
about
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementDecline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogsHydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line.Induction of cytokine expression by leukemia inhibitory factorPain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory painAssociations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee.The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid.Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosisIL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytesLeukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritisAndrogen receptors and experimental bone loss - an in vivo and in vitro study.Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritisClinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinomaComparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.Cytokines in contextDifferences in levels of inflammatory mediators in meniscal and synovial tissue of patients with meniscal lesions.A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cellsThe effects of adipokines on cartilage and meniscus catabolismSelective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development.Monocyte subsets in schistosomiasis patients with periportal fibrosisDuality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis.IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responsesMessenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.Alterations in the Secretome of Clinically Relevant Preparations of Adipose-Derived Mesenchymal Stem Cells Cocultured with Hyaluronan.Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines
P2860
Q24798439-5D9C67B9-20FA-4AB8-87E3-7DED99EB0058Q28345021-59AEF2E9-807F-44E5-A585-01DF458DE293Q33487779-433B9C40-7964-49CA-A1D3-2D403C362EB0Q33896044-C146D444-E2E5-4578-BF23-2A04047D0461Q33934561-0D9C0A8F-2FAF-431B-BCDB-8E41553CB192Q33946057-9A506B86-B3D8-4226-8F0F-9490D3468018Q35092953-5BB66B4D-9E7F-4062-8F7F-13A5F8585891Q35604825-A9382332-9308-44E4-972F-98CD6E4A0CF6Q35605220-26103378-CBA0-4D4E-A857-5CAF4A7645E9Q35764453-22077768-A26B-43ED-B0F8-CD308EDCBCADQ35766246-38FE6E69-104E-4C68-AE89-8A3E0AA053B4Q35821809-7DF8C82D-C860-4BDE-96FF-3536E274F623Q36269340-8E80CAA0-0D9C-4D91-87F3-4FC08DDF68DBQ36294719-806DE01C-03AB-4171-BAEB-E91B7BDDDA3BQ36430937-B351F0DB-2682-47BF-B8E9-31B3FEDDA5E8Q36439161-5363E6A2-2CB5-4213-8951-91F7C29F0740Q36529819-B90AE19C-FF47-402C-833A-12FC69B25979Q36541382-091237A4-9134-418C-80E9-8C40F82C20F1Q36648938-4F77194E-ECAA-4848-9076-7B7D5BFF758AQ36741296-7EA922B6-3F94-439E-960E-E69E4C373DEBQ37361642-7A494C36-ED61-4E84-9ABF-8B615048B6F7Q37386958-5F1330F4-C7E7-4DE6-AF34-73F8CC1EB087Q37686798-11A7B242-4E84-4945-B83D-F1575E64FC9AQ38059458-69AFC8F4-7221-41A5-A4EB-B12045C52840Q38896849-A12058C6-B345-4B72-B683-5C046C04D362Q39797207-9E1B57EB-C4B0-4306-8B25-FEC6ED1184F7Q42009063-2F5E4905-36AE-43A1-9DA0-62310C2642E9Q42040579-55DAD890-CB06-4820-A952-3A0AAAF583F1Q42159855-CC31BF4C-C98F-47A1-A84F-C166ECBE7803
P2860
Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA).
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Interleukin-6 induces the synt ...... tiating activity (TIMP-1/EPA).
@en
Interleukin-6 induces the synt ...... rythroid potentiating activity
@nl
type
label
Interleukin-6 induces the synt ...... tiating activity (TIMP-1/EPA).
@en
Interleukin-6 induces the synt ...... rythroid potentiating activity
@nl
prefLabel
Interleukin-6 induces the synt ...... tiating activity (TIMP-1/EPA).
@en
Interleukin-6 induces the synt ...... rythroid potentiating activity
@nl
P1476
Interleukin-6 induces the synt ...... tiating activity (TIMP-1/EPA).
@en
P2093
P304
P407
P577
1991-02-01T00:00:00Z